ATE456558T1 - Gabanerge modulatoren - Google Patents
Gabanerge modulatorenInfo
- Publication number
- ATE456558T1 ATE456558T1 AT04763813T AT04763813T ATE456558T1 AT E456558 T1 ATE456558 T1 AT E456558T1 AT 04763813 T AT04763813 T AT 04763813T AT 04763813 T AT04763813 T AT 04763813T AT E456558 T1 ATE456558 T1 AT E456558T1
- Authority
- AT
- Austria
- Prior art keywords
- gabanergic
- modulators
- gabanergic modulators
- Prior art date
Links
- 230000003371 gabaergic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49517903P | 2003-08-14 | 2003-08-14 | |
| US57438404P | 2004-05-25 | 2004-05-25 | |
| PCT/EP2004/008767 WO2005016892A1 (en) | 2003-08-14 | 2004-08-05 | Gabanergic modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456558T1 true ATE456558T1 (de) | 2010-02-15 |
Family
ID=34198028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04763813T ATE456558T1 (de) | 2003-08-14 | 2004-08-05 | Gabanerge modulatoren |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7365211B2 (de) |
| EP (1) | EP1656353B1 (de) |
| JP (1) | JP2007502257A (de) |
| KR (1) | KR100742014B1 (de) |
| AR (1) | AR045255A1 (de) |
| AT (1) | ATE456558T1 (de) |
| AU (1) | AU2004265101B2 (de) |
| BR (1) | BRPI0413540A (de) |
| CA (1) | CA2535406A1 (de) |
| DE (1) | DE602004025354D1 (de) |
| MX (1) | MXPA06001660A (de) |
| RU (1) | RU2376292C2 (de) |
| TW (1) | TW200524878A (de) |
| WO (1) | WO2005016892A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794518B1 (en) * | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
| US7592363B2 (en) * | 2004-08-03 | 2009-09-22 | Wyeth | Indazoles |
| CN101437519A (zh) | 2006-03-31 | 2009-05-20 | 艾博特公司 | 吲唑化合物 |
| MX2008012952A (es) * | 2006-04-11 | 2008-10-15 | Hoffmann La Roche | Moduladores heterociclicos del receptor selectivo del subtipo alfa de gaba. |
| JP2010513381A (ja) * | 2006-12-22 | 2010-04-30 | エフ．ホフマン−ラ ロシュ アーゲー | （３ｒ，４ｒ）−ｎ−（４−クロロフェニル）−１−（２，２−ジフルオロエチル）−ｎ’−［２−フルオロ−４−（２−オキソ−１（２ｈ）−ピリジニル）フェニル］−３，４−ピロリジンジカルボキサミドの製造方法 |
| HUE029127T2 (en) | 2007-05-15 | 2017-02-28 | Merial Inc | Arylazol-2-yl-cyanoethylamino compounds, a process for their preparation and use |
| RS58508B1 (sr) | 2008-11-14 | 2019-04-30 | Merial Inc | Enantiomerno obogaćena paraziticidalna jedinjenja ariloazol-2-il cijanoetilamino |
| WO2010089292A1 (en) | 2009-02-06 | 2010-08-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| EP2427453B1 (de) | 2009-05-07 | 2013-07-17 | Janssen Pharmaceuticals, Inc. | Substituierte indazol- und azaindazol-derivate als gamma-secretase-modulatoren |
| EA021047B1 (ru) | 2009-07-15 | 2015-03-31 | Янссен Фармасьютикалз, Инк. | Замещенные производные триазола и имидазола в качестве модуляторов гамма-секретазы |
| PE20121511A1 (es) | 2010-01-15 | 2012-12-06 | Janssen Pharmaceuticals Inc | Novedosos derivados biciclicos de triazol sustituidos como moduladores de gamma secretasa |
| EP2582666B1 (de) * | 2010-06-16 | 2014-08-13 | Purdue Pharma L.P. | Arylsubstituierte indole und ihre verwendung als kalzium-kanal-blocker |
| CA2827969A1 (en) | 2011-03-24 | 2012-09-27 | Janssen Pharmaceuticals, Inc. | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
| EA023045B1 (ru) | 2011-07-15 | 2016-04-29 | Янссен Фармасьютикалз, Инк. | Новые замещенные производные индола в качестве модуляторов гамма-секретазы |
| JP6106745B2 (ja) | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | （特に）アルツハイマー病の治療に有用な置換３，４−ジヒドロ−２Ｈ−ピリド［１，２−ａ］ピラジン−１，６−ジオン誘導体 |
| JP2014034523A (ja) * | 2012-08-07 | 2014-02-24 | Manac Inc | モノまたはジハロゲノピリジルアミン類の製造方法 |
| US8822689B2 (en) | 2012-09-19 | 2014-09-02 | Merial Limited | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| EP2927229B1 (de) | 2012-10-16 | 2018-09-05 | Takeda Pharmaceutical Company Limited | Zur vorbeugung oder behandlung von neurodegenerativen erkrankungen oder epilepsie geeignete benzol-kondensierte fünfgliedrige stickstoff enthaltende heteroaromatische verbindungen |
| US10112943B2 (en) | 2012-12-20 | 2018-10-30 | Janssen Pharmaceutica Nv | Substituted imidazoles as gamma secretase modulators |
| WO2014111457A1 (en) | 2013-01-17 | 2014-07-24 | Janssen Pharmaceutica Nv | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
| US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
| US20190292188A1 (en) | 2018-02-27 | 2019-09-26 | Incyte Corporation | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors |
| WO2019200061A1 (en) * | 2018-04-11 | 2019-10-17 | The General Hospital Corporation | Anesthetic compounds |
| MA52940A (fr) | 2018-05-18 | 2021-04-28 | Incyte Corp | Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b |
| CN113166153B (zh) | 2018-07-05 | 2024-11-01 | 因赛特公司 | 作为a2a/a2b抑制剂的稠合吡嗪衍生物 |
| US10562930B1 (en) | 2018-08-31 | 2020-02-18 | Praxis Precision Medicines, Inc. | Salts and crystal forms of GABAA positive allosteric modulator |
| WO2020065642A1 (en) | 2018-09-25 | 2020-04-02 | Pepticom Ltd. | Positive allosteric modulators of gabaa receptor |
| EP3870292A4 (de) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | Kombination von serotonin-spezifischem wiederaufnahmeinhibitor und serotonin-1a-rezeptor-partialagonist zur verminderung von l-dopa-induzierter dyskinesie |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
| WO2022006541A1 (en) * | 2020-07-02 | 2022-01-06 | Praxis Precision Medicines, Inc. | Methods for the treatment of adjustment disorder |
| CN116462628A (zh) * | 2022-01-12 | 2023-07-21 | 联化科技新材(台州)有限公司 | 一种2-溴-5-氨基吡啶的制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2251820C (en) * | 1996-04-19 | 2007-03-27 | Akzo Nobel Nv | Substituted benzylamines and their use for the treatment of depression |
| GB9801538D0 (en) * | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| US6653304B2 (en) * | 2000-02-11 | 2003-11-25 | Bristol-Myers Squibb Co. | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| GB0008696D0 (en) * | 2000-04-07 | 2000-05-31 | Merck Sharp & Dohme | Therapeutic agents |
| AU2001267963A1 (en) * | 2000-06-30 | 2002-01-08 | Light Eye Developments Limited | Improved dynamo |
| AU2001277621A1 (en) | 2000-08-09 | 2002-03-04 | Astrazeneca Ab | Antiangiogenic bicyclic derivatives |
| CA2419966A1 (en) * | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| BR0316950A (pt) * | 2002-12-02 | 2006-01-17 | Hoffmann La Roche | Derivados de indazol como antagonistas de crf |
-
2004
- 2004-08-05 MX MXPA06001660A patent/MXPA06001660A/es active IP Right Grant
- 2004-08-05 DE DE602004025354T patent/DE602004025354D1/de not_active Expired - Lifetime
- 2004-08-05 WO PCT/EP2004/008767 patent/WO2005016892A1/en not_active Ceased
- 2004-08-05 AT AT04763813T patent/ATE456558T1/de not_active IP Right Cessation
- 2004-08-05 CA CA002535406A patent/CA2535406A1/en not_active Abandoned
- 2004-08-05 RU RU2006107438/04A patent/RU2376292C2/ru not_active IP Right Cessation
- 2004-08-05 AU AU2004265101A patent/AU2004265101B2/en not_active Ceased
- 2004-08-05 EP EP04763813A patent/EP1656353B1/de not_active Expired - Lifetime
- 2004-08-05 JP JP2006522959A patent/JP2007502257A/ja active Pending
- 2004-08-05 BR BRPI0413540-7A patent/BRPI0413540A/pt not_active IP Right Cessation
- 2004-08-05 KR KR1020067002966A patent/KR100742014B1/ko not_active Expired - Fee Related
- 2004-08-11 US US10/916,073 patent/US7365211B2/en not_active Expired - Fee Related
- 2004-08-11 TW TW093124065A patent/TW200524878A/zh unknown
- 2004-08-12 AR ARP040102881A patent/AR045255A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007502257A (ja) | 2007-02-08 |
| AU2004265101B2 (en) | 2009-06-11 |
| RU2006107438A (ru) | 2007-09-20 |
| US7365211B2 (en) | 2008-04-29 |
| AU2004265101A1 (en) | 2005-02-24 |
| KR100742014B1 (ko) | 2007-07-23 |
| WO2005016892A1 (en) | 2005-02-24 |
| DE602004025354D1 (de) | 2010-03-18 |
| BRPI0413540A (pt) | 2006-10-10 |
| RU2376292C2 (ru) | 2009-12-20 |
| US20050101614A1 (en) | 2005-05-12 |
| TW200524878A (en) | 2005-08-01 |
| AR045255A1 (es) | 2005-10-19 |
| CA2535406A1 (en) | 2005-02-24 |
| EP1656353A1 (de) | 2006-05-17 |
| KR20060037440A (ko) | 2006-05-03 |
| MXPA06001660A (es) | 2006-04-28 |
| EP1656353B1 (de) | 2010-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE456558T1 (de) | Gabanerge modulatoren | |
| DE602004026540D1 (de) | Kurbelwellenmomentmodulator | |
| FI20020800A7 (fi) | Modulaattori | |
| IS2813B (is) | Þalasínónafleiður | |
| DE602004011161D1 (de) | Kraftfahrzeugschliessanlage | |
| IS2918B (is) | Múskarínasetýlkólínviðtakamótlyf | |
| DE50311766D1 (de) | Onanzfrequenz | |
| IS8412A (is) | Kínasólínafleiður | |
| DE602004018967D1 (de) | Amidoacetonitrilderivate | |
| DE502004010381D1 (de) | Um | |
| DE602004020304D1 (de) | Rantennensystemen | |
| NO20030424D0 (no) | Brönnhodeplattform | |
| DK2447252T3 (da) | Theramuteinmodulatorer | |
| DE60330065D1 (de) | Kugelgelenk | |
| DE60331697D1 (de) | Verzögerungszeitdiskriminator | |
| DE602004024235D1 (de) | Amidoacetonitrilderivate | |
| DE602004018247D1 (de) | Modulator | |
| ATE446959T1 (de) | Chromenonindole | |
| DE602004013661D1 (de) | Spritzgiessnadelverschlussbuchse | |
| DK1581307T3 (da) | Irs modulatorer | |
| DE502004001629D1 (de) | Bremsenprüfstand | |
| DE502004002978D1 (de) | N-biarylamide | |
| DE502004008889D1 (de) | Schaltgabel | |
| DE502004000518D1 (de) | Mitgängergabelhubwagen | |
| DE112004002227D2 (de) | Nietverarbeitungsgerät |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |